Advaxis

ADXS NASDAQ
0.4150
-0.0050
-1.19%
交易中 14:26 08/22 EDT
开盘
0.4200
昨收
0.4200
最高
0.4229
最低
0.4004
成交量
36.45万
成交均量(3M)
50.16万
52周最高
23.70
52周最低
0.3551
换手率
2.12%
市值
714.65万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Advaxis ADXS股票价格,Advaxis股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer.
展开 >

最近浏览

名称
价格
涨跌幅